Between June and July 2025, when the formulary change was implemented, switching from AOM tirzepatide increased, while patients with an active supply of AOM semaglutide showed stable or even slightly reduced switching during the same period, consistent with its designation as the preferred option
Data extraction was conducted by two independent reviewers, with discrepancies resolved by a third reviewer
Lazarus or our PAs
That decision should be supervised medically
B12 can be an important part of treatment for various types of nerve pain
Adverse Events Subjects were asked to report any adverse events on each visit in terms of incidences of headache, dizziness, nausea, vomiting, heart palpitations, trouble swallowing pills, lethargy, memory loss, cramps, chest pain, wheezing, ear pain, indigestion, blood in urine, blood in stool, ringing in ears, lethargy, swelling, and itching